跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Oncotaxel Concentrate and solvent for solution for infusion 40 mg/ ml - HSA Drug Approval Details
Approvals
/
HSA
/
Oncotaxel Concentrate and solvent for solution for infusion 40 mg/ ml
Approved
THERAPEUTIC
Oncotaxel Concentrate and solvent for solution for infusion 40 mg/ ml
S.C. SINDAN-PHARMA S.R.LS.C. Sindan-Pharma S.R.L (Solvent)
🇸🇬 Health Sciences Authority
Approval Date
Jul 15, 2011
Approval ID
43f8e7b2f56c93c7
Company
S.C. SINDAN-PHARMA S.R.LS.C. Sindan-Pharma S.R.L (Solvent)
Type
Therapeutic
Approval Details
Approval Id
43f8e7b2f56c93c7
Drug Name
Oncotaxel Concentrate and solvent for solution for infusion 40 mg/ ml
Product Name
Oncotaxel Concentrate and solvent for solution for infusion 40 mg/ ml
Approval Number
SIN13987P
Approval Date
2011-07-15
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
SOLUTION, CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01CD02
Atc Item Name
docetaxel
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Docetaxel
40.0 mg/ ml
Docetaxel
40.0 mg/ ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 15, 2011
Approval ID
43f8e7b2f56c93c7
Type
Therapeutic
Back to HSA Approvals
